Formula Identification (FID) 114657 in Contact Lens Wearers

• Status: Completed
• Trial end date: 2015-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the thickness of the pre-lens tear lipid layer after 2 hours of lens wear with use of FID 114657 compared to saline control.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Ophthalmic Solutions; Tetrahydrozoline

Criteria

Inclusion Criteria:

• Must sign the informed consent form.

• Stable, tear lipid layer thickness ≤ 75 nm without contact lenses.

• Successfully wearing bi-weekly or monthly replacement soft contact lenses in both eyes for a minimum of 5 days/week during the past 2 months prior to Visit 1.

• Vision correctable to 20/25 Snellen (feet) or better at distance with habitual contact lenses at Visit 1.

• Willing to wear lenses 5 days a week, 8 hours a day for at least 2 days during the study.

• Demonstrate symptoms of contact lens discomfort.

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Routinely sleeping in lenses.

• Any active eye inflammation or condition that contraindicates contact lens wear.

• Any systemic diseases that could prevent successful contact lens wear.

• Use of systemic or ocular medications that contraindicate lens wear.

• Fit with only 1 contact lens.

• Unwilling to discontinue the use of cosmetics (such as eyeliner, mascara, or eye shadow) or facial creams on or around the eyelids on Day 1 and Day 14 of the study.

• Women of childbearing potential who are currently pregnant, test positive for pregnancy at Screening visit, breast feeding, or unwilling to use adequate birth control throughout the study.

• Other protocol-defined exclusion criteria may apply.